This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Dermatology
Different emollient formulations appear to be equally effective in childhood eczema
Read more
Older adults with atopic eczema at greater risk of developing Alzheimer’s disease
Read more
Cochrane systematic review answers only some questions on topical steroids use in eczema
Read more
Psoriasis patients self-report higher analgesic usage largely due to joint pain
Read more
Lirentelimab effective for refractory chronic urticaria
Read more
Tapinarof cream effective for moderately severe plaque psoriasis
Read more
Dupilumab reduces COVID-19 symptom burden in patients with atopic eczema
Read more
Topical asivatrep, a TRPVI antagonist, effective for adults with atopic eczema
Read more
Ruxolitinib cream significantly improves patient outcomes in atopic dermatitis
Read more
Chronic urticaria patients at risk of obstructive sleep apnoea
Read more
NICE approves Cosentyx for children and young people with psoriasis
Read more
Probiotics reduce risk of developing atopic eczema
Read more
Biologics most effective in treatment-resistant chronic spontaneous urticaria
Read more
EU approves bimekizumab for moderate to severe psoriasis
Read more
Upadacitinib superior at clearing atopic eczema compared with dupilumab
Read more
Network meta-analysis confirms superiority of biologics to small molecules in plaque psoriasis
Read more
Topical calcineurin inhibitor use associated with minimal increased risk of cancers
Read more
Page 4 of 7
« First
«
...
2
3
4
5
6
...
»
Last »
Popular articles
New protocol for IBD referral triage reduces diagnostic delays, say researchers
24 April, 2024
Ivacaftor use in cystic fibrosis ‘safe and effective’ from one month old, study finds
25 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
x
Search for: